PVCT · Provectus Biopharmaceuticals, Inc. · Documents
$0.05
0.00 (-3.01%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The aforementioned factors indicate that management's plans do not alleviate the substantial doubt about the Company's ability to continue as a going concern for a period of one year from the issuance of these financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$20.17M
Shares
420.28M
Volume · Oct 23
26.82K
Avg daily vol (3M)
109.98K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2020-01-07 | 2019-12-31 |
Showing 101–101 of 101 filings